DelveInsight Reports Sitemap

All Reports in this category
S.No. Product Name Actions
1 1,3-Beta-Glucan Synthase Inhibitor - Pipeline Insight, 2022 Report Link
2 11 Beta-Hydroxysteroid Dehydrogenase (11 HSD) Inhibitor - Pipeline Insight, 2022 Report Link
3 11 Beta-Hydroxysteroid Dehydrogenase Type 1 (11 HSD1) Inhibitor - Pipeline Insight, 2022 Report Link
4 20s Proteasome Inhibitor - Pipeline Insight, 2022 Report Link
5 30S Ribosomal Subunit (30S RNA) Inhibitor - Pipeline Insight, 2022 Report Link
6 4-1BB receptor Agonist - Pipeline Insight, 2022 Report Link
7 50S Ribosomal Subunit (50S RNA) Inhibitor - Pipeline Insight, 2022 Report Link
8 5-Alpha Reductase Inhibitor - Pipeline Insight, 2022 Report Link
9 5-HT1 Agonist - Pipeline Insight, 2022 Report Link
10 5-HT1 Antagonist - Pipeline Insight, 2022 Report Link
11 5-HT1A Antagonist - Pipeline Insight, 2022 Report Link
12 5-HT1B Agonist - Pipeline Insight, 2022 Report Link
13 5-HT1B Antagonist - Pipeline Insight, 2022 Report Link
14 5-HT1D Agonist - Pipeline Insight, 2022 Report Link
15 5-HT2 Agonist - Pipeline Insight, 2022 Report Link
16 5-HT2 Antagonist - Pipeline Insight, 2022 Report Link
17 5-HT2A Agonist - Pipeline Insight, 2022 Report Link
18 5-HT2B Antagonist - Pipeline Insight, 2022 Report Link
19 5-HT2C Agonist - Pipeline Insight, 2022 Report Link
20 5-HT2C Antagonist - Pipeline Insight, 2022 Report Link
21 5-HT4 Agonist - Pipeline Insight, 2022 Report Link
22 5-HT4 Antagonist - Pipeline Insight, 2022 Report Link
23 5-HT4 Partial Agonist - Pipeline Insight, 2022 Report Link
24 5-HT6 Antagonist - Pipeline Insight, 2022 Report Link
25 5-HT7 Antagonist - Pipeline Insight, 2022 Report Link
26 GABAB Agonist - Pipeline Insight, 2022 Report Link
27 Galectin Inhibitor - Pipeline Insight, 2022 Report Link
28 Gamma Secretase Inhibitor - Pipeline Insight, 2022 Report Link
29 Ghrelin Receptor Agonist - Pipeline Insight, 2022 Report Link
30 Glucagon Receptor Antagonist - Pipeline Insight, 2022 Report Link
31 Glucagon-Like Peptide (GLP) Agonist - Pipeline Insight, 2022 Report Link
32 Glucocorticoid induced tumor necrosis factor - Pipeline Insight, 2022 Report Link
33 Glucocorticoid Receptor Antagonist - Pipeline Insight, 2022 Report Link
34 Glucokinase Activators - Pipeline Insight, 2022 Report Link
35 Glucosylceramide Synthase Inhibitor - Pipeline Insight, 2022 Report Link
36 Glutamate Receptor Antagonist - Pipeline Insight, 2022 Report Link
37 Glycan Inhibitor - Pipeline Insight, 2022 Report Link
38 Glycine Transporter Type-1 (Glyt-1) Inhibitor - Pipeline Insight, 2022 Report Link
39 Glycogen Synthase Kinase 3 (GSK-3) Inhibitor - Pipeline Insight, 2022 Report Link
40 GM-CSF Inhibitor - Pipeline Insight, 2022 Report Link
41 Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Antagonist - Pipeline Insight, 2022 Report Link
42 G-Protein Coupled Receptor (GPCR) Agonist - Pipeline Insight, 2022 Report Link
43 Growth Hormone (GH) Agonist - Pipeline Insight, 2022 Report Link
44 Growth Hormone Antagonist - Pipeline Insight, 2022 Report Link
45 Guanylate Cyclase (Guanyl Cyclase or Guanylyl Cyclase or GC) Activators - Pipeline Insight, 2022 Report Link
46 Guanylate Cyclase-Coupled Receptor Activators - Pipeline Insight, 2022 Report Link
47 H Antagonist - Pipeline Insight, 2022 Report Link
48 H 2 Antagonist - Pipeline Insight, 2022 Report Link
49 H 3 Antagonist - Pipeline Insight, 2022 Report Link
50 H 4 Antagonist - Pipeline Insight, 2022 Report Link
51 Matrix Metalloproteinase 9 (MMP-9) Inhibitor - Pipeline Insight, 2022 Report Link
52 Melanocortin 4 Receptor (MC4R) Agonist - Pipeline Insight, 2022 Report Link
53 Metabotropic Glutamate Receptor Agonist - Pipeline Insight, 2022 Report Link
54 Methionine Aminopeptidase 2 (Metap2) Inhibitor - Pipeline Insight, 2022 Report Link
55 mGlu 2/3 Agonist - Pipeline Insight, 2022 Report Link
56 mGlu 2/3/5 Antagonist - Pipeline Insight, 2022 Report Link
57 mGlu5 Antagonist - Pipeline Insight, 2022 Report Link
58 Mitochondrial Electron Transport Inhibitor - Pipeline Insight, 2022 Report Link
59 Mitogen Activated Protein Kinase Kinase (MEK or MAP2K) Inhibitor - Pipeline Insight, 2022 Report Link
60 Mitogen Activated Protein Kinase Kinase 2 (MEK-2 or MAP2K2) Inhibitor - Pipeline Insight, 2022 Report Link
61 Monoamine Oxidase Inhibitor (MAOIs) - Pipeline Insight, 2022 Report Link
62 Monoamine Oxidase B (MAO-B) Inhibitor - Pipeline Insight, 2022 Report Link
63 mTORC-1 Inhibitor - Pipeline Insight, 2022 Report Link
64 mTORC-2 Inhibitor - Pipeline Insight, 2022 Report Link
65 Mu Antagonist - Pipeline Insight, 2022 Report Link
66 Murine Double Minute 2 (MDM2) Inhibitor - Pipeline Insight, 2022 Report Link
67 Muscarinic Acetylcholine Receptor (mAChR) Antagonist - Pipeline Insight, 2022 Report Link
68 Muscarinic Acetylcholine Receptor M2 Antagonist - Pipeline Insight, 2022 Report Link
69 Muscarinic Acetylcholine Receptor M3 Antagonist - Pipeline Insight, 2022 Report Link
70 Muscarinic Agonist - Pipeline Insight, 2022 Report Link
71 Muscarinic M1 Agonist - Pipeline Insight, 2022 Report Link
72 Myostatin Inhibitor - Pipeline Insight, 2022 Report Link
73 Neurokinin (NK) Receptor Antagonist - Pipeline Insight, 2022 Report Link
74 Neurokinin 1 (NK1) Receptor Agonist - Pipeline Insight, 2022 Report Link
75 Neuronal Nitric Oxide Synthase (nNOS or Type I NOS) Inhibitor - Pipeline Insight, 2022 Report Link
76 Heat Shock Protein (Hsp) Inhibitor - Pipeline Insight, 2022 Report Link
77 Hedgehog Signaling Pathway Antagonist - Pipeline Insight, 2022 Report Link
78 Hepatitis C Virus (HCV) Protease Inhibitor - Pipeline Insight, 2022 Report Link
79 Interleukin-2 (IL-2) Inhibitor - Pipeline Insight, 2022 Report Link
80 Hepcidin Antagonist - Pipeline Insight, 2022 Report Link
81 Interleukin-2 (IL-2) Receptor Agonist - Pipeline Insight, 2022 Report Link
82 HIF-1 Alpha Inhibitor - Pipeline Insight, 2022 Report Link
83 Interleukin-23 (IL-23) Inhibitor - Pipeline Insight, 2022 Report Link
84 HIV Attachment Inhibitor - Pipeline Insight, 2022 Report Link
85 Interleukin-4 (IL-4) Inhibitor - Pipeline Insight, 2022 Report Link
86 Human Epidermal Growth Factor Receptor 4 (HER-4 or ErbB-4) Inhibitor - Pipeline Insight, 2022 Report Link
87 Interleukin-5 (IL-5) Inhibitor - Pipeline Insight, 2022 Report Link
88 Hypoxia Inducible Factor 1 (HIF-1) Inhibitor - Pipeline Insight, 2022 Report Link
89 Interleukin-8 (IL-8) Inhibitor - Pipeline Insight, 2022 Report Link
90 Hypoxia Inducible Factor Prolyl-4-Hydroxylase (HIF-PH) Inhibitor - Pipeline Insight, 2022 Report Link
91 Ionotropic Glutamate Receptor Antagonist - Pipeline Insight, 2022 Report Link
92 IkappaB Kinase (IKK) Inhibitor - Pipeline Insight, 2022 Report Link
93 IL-6 Receptor Antagonist - Pipeline Insight, 2022 Report Link
94 Mayus Kinase (JAK) Inhibitor - Pipeline Insight, 2022 Report Link
95 Inducible Nitric Oxide Synthase (iNOS or Type II NOS) Inhibitor - Pipeline Insight, 2022 Report Link
96 Mayus Kinase 1 (JAK1) Inhibitor - Pipeline Insight, 2022 Report Link
97 Inhibitor of Apoptosis (IAP) Antagonist - Pipeline Insight, 2022 Report Link
98 Mayus Kinase 3 (JAK3) Inhibitor - Pipeline Insight, 2022 Report Link
99 Insulin Like Growth Factor (IGF) Inhibitor - Pipeline Insight, 2022 Report Link
100 Kainate Receptor Antagonist - Pipeline Insight, 2022 Report Link
101 Insulin Like Growth Factor 1 (IGF-1) Activators - Pipeline Insight, 2022 Report Link
102 Kallikrein Inhibitor - Pipeline Insight, 2022 Report Link
103 Integrase Inhibitor - Pipeline Insight, 2022 Report Link
104 Kappa Antagonist - Pipeline Insight, 2022 Report Link
105 Integrin Alpha 4beta1/Very Late Antigen-4 (VLA-4) Inhibitor - Pipeline Insight, 2022 Report Link
106 Kv1.3/1.5 Potassium Channel Blockers - Pipeline Insight, 2022 Report Link
107 interleukin Agonist - Pipeline Insight, 2022 Report Link
108 Kv1.3 Potassium Channel Blockers - Pipeline Insight, 2022 Report Link
109 Interleukin-1 (IL-1) Inhibitor - Pipeline Insight, 2022 Report Link
110 LAG-3 Antagonist - Pipeline Insight, 2022 Report Link
111 Interleukin-10 (IL-10) Receptor Agonist - Pipeline Insight, 2022 Report Link
112 Leucine-Rich Repeat Kinase (LRRK)-2 Inhibitor - Pipeline Insight, 2022 Report Link
113 Interleukin-12 (IL-12) Inhibitor - Pipeline Insight, 2022 Report Link
114 Leukotriene Antagonist - Pipeline Insight, 2022 Report Link
115 Interleukin-13 (IL-13) Inhibitor - Pipeline Insight, 2022 Report Link
116 Leukotriene D4 Antagonist - Pipeline Insight, 2022 Report Link
117 Interleukin-17 (IL-17) Inhibitor - Pipeline Insight, 2022 Report Link
118 Neutrophil Elastase Inhibitor - Pipeline Insight, 2022 Report Link
119 Lipoxygenase Inhibitor (LOX Inhibitor) - Pipeline Insight, 2022 Report Link
120 Interleukin-18 (IL-18) Inhibitor - Pipeline Insight, 2022 Report Link
121 NMDA Receptor Antagonist - Pipeline Insight, 2022 Report Link
122 Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitor - Pipeline Insight, 2022 Report Link
123 Non Selective COX Inhibitor - Pipeline Insight, 2022 Report Link
124 PI3K/mTOR Pathway Inhibitor - Pipeline Insight, 2022 Report Link
125 Lysine Specific Demethylase 1 (LSD-1) Inhibitors - Pipeline Insight, 2022 Report Link
126 Non-Receptor Tyrosine Kinase Inhibitor - Pipeline Insight, 2022 Report Link
127 Matrix Metalloproteinase (MMP) Inhibitor - Pipeline Insight, 2022 Report Link
128 Pim Kinase Inhibitor - Pipeline Insight, 2022 Report Link
129 Matrix Metalloproteinase 12 (MMP-12 or Macrophage Metalloelastase) Inhibitor - Pipeline Insight, 2022 Report Link
130 Non-Structural Protein 5 Inhibitor - Pipeline Insight, 2022 Report Link
131 Plasmin Inhibitor - Pipeline Insight, 2022 Report Link
132 Noradrenaline Transporter (NAT or Norepinephrine Transporter or NET) Inhibitor - Pipeline Insight, 2022 Report Link
133 Plasminogen Activator Inhibitor - Pipeline Insight, 2022 Report Link
134 Notch Signaling Pathway Inhibitor - Pipeline Insight, 2022 Report Link
135 Plasminogen Activator Inhibitor-1 (PAI-1) - Pipeline Insight, 2022 Report Link
136 Nrf2 Pathway Activators - Pipeline Insight, 2022 Report Link
137 Plasminogen Activators - Pipeline Insight, 2022 Report Link
138 Nucleotide Analog Reverse Transcriptase Inhibitor (NtRTI)s - Pipeline Insight, 2022 Report Link
139 Platelet Derived Growth Factor Inhibitor - Pipeline Insight, 2022 Report Link
140 Opioid Receptor Agonist - Pipeline Insight, 2022 Report Link
141 Polo-Like Kinase Inhibitor - Pipeline Insight, 2022 Report Link
142 Orexin Receptor (Hypocretin Receptor) Antagonist - Pipeline Insight, 2022 Report Link
143 Polo-Like Kinase 1 (PLK1 ) Inhibitor - Pipeline Insight, 2022 Report Link
144 Ornithine Decarboxylase (ODC) Inhibitor - Pipeline Insight, 2022 Report Link
145 Poly (ADP-Ribose) Polymerase 1 (PARP) Inhibitor - Pipeline Insight, 2022 Report Link
146 OX-40 Agonist - Pipeline Insight, 2022 Report Link
147 Potassium Channel Openers - Pipeline Insight, 2022 Report Link
148 P2X7 Receptor Antagonist - Pipeline Insight, 2022 Report Link
149 PPAR-Beta / Delta Agonist - Pipeline Insight, 2022 Report Link
150 P2Y12 Platelet ADP Receptor Antagonist - Pipeline Insight, 2022 Report Link
151 Progesterone Receptor (PR) Antagonist - Pipeline Insight, 2022 Report Link
152 p70S6 Kinase (p70S6K or 70-kDa Ribosomal Protein S6 Kinase) Inhibitor - Pipeline Insight, 2022 Report Link
153 Progesterone Receptor Agonist - Pipeline Insight, 2022 Report Link
154 Parathyroid Hormone Receptor Agonist - Pipeline Insight, 2022 Report Link
155 Prolactin Receptor Antagonist - Pipeline Insight, 2022 Report Link
156 PDE Inhibitor - Pipeline Insight, 2022 Report Link
157 Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor - Pipeline Insight, 2022 Report Link
158 PDE 1 Inhibitor - Pipeline Insight, 2022 Report Link
159 Prostaglandin Antagonist - Pipeline Insight, 2022 Report Link
160 PDE 10 inhibitor - Pipeline Insight, 2022 Report Link
161 Protein Kinase C (PKC) Inhibitor - Pipeline Insight, 2022 Report Link
162 Penicillin-Binding Proteins (PBPs) Inhibitor - Pipeline Insight, 2022 Report Link
163 Protein-Tyrosine Phosphatase (PTP) Inhibitor - Pipeline Insight, 2022 Report Link
164 Peroxisome Proliferator-Activated Receptor (PPAR) Agonist - Pipeline Insight, 2022 Report Link
165 Protein-Tyrosine Phosphatase 1B (PTP1B) Inhibitor - Pipeline Insight, 2022 Report Link
166 Phosphoinositide 3-Kinase Beta (PI3K Beta) Inhibitor - Pipeline Insight, 2022 Report Link
167 Purinergic Receptor (Purinoceptor) Antagonist - Pipeline Insight, 2022 Report Link
168 Phosphoinositide 3-Kinase Delta (PI3K Delta) Inhibitor - Pipeline Insight, 2022 Report Link
169 Renin Inhibitor - Pipeline Insight, 2022 Report Link
170 RET (Ret Proto-Oncogene) protein Inhibitor - Pipeline Insight, 2022 Report Link
171 Retinoic Acid Receptors (RARs) Agonist - Pipeline Insight, 2022 Report Link
172 Reversible Anticholinesterases - Pipeline Insight, 2022 Report Link
173 TGF-Beta-1 Inhibitor - Pipeline Insight, 2022 Report Link
174 TGF-Beta-2 Inhibitor - Pipeline Insight, 2022 Report Link
175 Tie-2 modulators - Pipeline Insight, 2022 Report Link
176 Tie-2 Receptor Inhibitor - Pipeline Insight, 2022 Report Link
177 TIM-3 Antagonist - Pipeline Insight, 2022 Report Link
178 Toll- Like Receptor Agonist - Pipeline Insight, 2022 Report Link
179 Toll-Like Receptor 4 (TLR-4) Agonist - Pipeline Insight, 2022 Report Link
180 Toll-Like Receptor 7, 8 (TLR-8) Agonist - Pipeline Insight, 2022 Report Link
181 Toll-Like Receptor 9 (TLR-9) Modulator - Pipeline Insight, 2022 Report Link
182 Toll-Like Receptor Modulators - Pipeline Insight, 2022 Report Link
183 Topoisomerase Inhibitor - Pipeline Insight, 2022 Report Link
184 TRAIL Receptor 1 & Receptor 2 Agonist - Pipeline Insight, 2022 Report Link
185 Transforming Growth Factor (TGF) Inhibitor - Pipeline Insight, 2022 Report Link
186 Transient Receptor Potential Cation Channel, Subfamily A, Member 1 (TRPA1) Antagonist - Pipeline Insight, 2022 Report Link
187 Transient Receptor Potential Cation Channel, Subfamily M, Member 8 (TRPM8) Antagonist - Pipeline Insight, 2022 Report Link
188 Transient Receptor Potential Vanilloid 1 (TRPV-1) Receptor (Capsaicin Receptor or Vanilloid Receptor 1) Agonist - Pipeline Insight, 2022 Report Link
189 Transient Receptor Potential Vanilloid 1 (TRPV-1) Receptor (Capsaicin Receptor or Vanilloid Receptor 1) Antagonist - Pipeline Insight, 2022 Report Link
190 TRK1-Transforming Tyrosine Kinase (Trk-A or High Affinity Nerve Growth Factor Receptor) Antagonist - Pipeline Insight, 2022 Report Link
191 Tumor Necrosis Factor Alpha (TNF-a) Agonist - Pipeline Insight, 2022 Report Link
192 Type 1 Lysophosphatidic Acid Receptor (LPA1) Inhibitor - Pipeline Insight, 2022 Report Link
193 Ubiquitin conjugating enzyme Inhibitor - Pipeline Insight, 2022 Report Link
194 Ubiquitin Specific Proteases (USP) Inhibitor - Pipeline Insight, 2022 Report Link
195 Vascular Endothelial Growth Factor Inhibitor - Pipeline Insight, 2022 Report Link
196 Rho Kinase (Rho-Associated Coiled-Coil Forming Protein Kinase or ROCK) Inhibitor - Pipeline Insight, 2022 Report Link
197 RNA-Dependent RNA Polymerase (RdRP or RNA Replicase) Inhibitor - Pipeline Insight, 2022 Report Link
198 RON (Recepteur d'origine Nantais) Inhibitor - Pipeline Insight, 2022 Report Link
199 Sclerostin Inhibitor - Pipeline Insight, 2022 Report Link
200 Secretase Inhibitor - Pipeline Insight, 2022 Report Link
201 Selectin Inhibitor - Pipeline Insight, 2022 Report Link
202 Selective COX-2 Inhibitor - Pipeline Insight, 2022 Report Link
203 Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor - Pipeline Insight, 2022 Report Link
204 Serotonin Reuptake Inhibitor (SRI) - Pipeline Insight, 2022 Report Link
205 Serotonin Transporter Inhibitor - Pipeline Insight, 2022 Report Link
206 Sigma Receptor Agonist - Pipeline Insight, 2022 Report Link
207 Sodium Dependent Glucose Transporter 1 (SGLT1) Inhibitor - Pipeline Insight, 2022 Report Link
208 Somatostatin Receptor Agonist - Pipeline Insight, 2022 Report Link
209 Sphingosine 1-Phosphate (S1P) Inhibitor - Pipeline Insight, 2022 Report Link
210 Sphingosine 1-Phosphate (S1P) Receptor Agonist - Pipeline Insight, 2022 Report Link
211 Squalene Epoxidase Inhibitor - Pipeline Insight, 2022 Report Link
212 SRC Family Kinases (SFK) Inhibitor - Pipeline Insight, 2022 Report Link
213 Sterol 14 Alpha-Demethylase Inhibitor - Pipeline Insight, 2022 Report Link
214 Superoxide Dismutase (SOD) Inhibitor - Pipeline Insight, 2022 Report Link
215 T Cell Inhibitor - Pipeline Insight, 2022 Report Link
216 Tau Inhibitor - Pipeline Insight, 2022 Report Link
217 Telomerase Inhibitor - Pipeline Insight, 2022 Report Link
218 Tetrahydrofolate Dehydrogenase Inhibitor - Pipeline Insight, 2022 Report Link
219 TGF-Beta Inhibitor - Pipeline Insight, 2022 Report Link
220 Vascular Endothelial Growth Factor A (VEGF-A) Inhibitor - Pipeline Insight, 2022 Report Link
221 Vasopressin Receptor Antagonist - Pipeline Insight, 2022 Report Link
222 Vasopressin V1 Receptor (V1R) Antagonist - Pipeline Insight, 2022 Report Link
223 Vasopressin V2 Receptor (V2R) Agonist - Pipeline Insight, 2022 Report Link
224 Vasopressin V2 Receptor (V2R) Antagonist - Pipeline Insight, 2022 Report Link
225 VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor - Pipeline Insight, 2022 Report Link
226 Viral RNA Polymerase Inhibitor - Pipeline Insight, 2022 Report Link
227 5-Lipoxygenase Inhibitor (Arachidonate 5-Lipoxygenase Inhibitor) - Pipeline Insight, 2022 Report Link
228 Vitamin D Receptor (VDR or Calcitriol Receptor) Agonist - Pipeline Insight, 2022 Report Link
229 Acetylcholine Receptor (AChR) Antagonist - Pipeline Insight, 2022 Report Link
230 Voltage-Dependent Calcium Channel Blockers - Pipeline Insight, 2022 Report Link
231 Adenosine A1 Receptor Agonist - Pipeline Insight, 2022 Report Link
232 Alpha-1 Antagonist - Pipeline Insight, 2022 Report Link
233 Voltage-Dependent T-Type Calcium Channel Blockers - Pipeline Insight, 2022 Report Link
234 Adenosine A1 Receptor Antagonist - Pipeline Insight, 2022 Report Link
235 Voltage-Gated Sodium Channel Blockers - Pipeline Insight, 2022 Report Link
236 Alpha-1A Antagonist - Pipeline Insight, 2022 Report Link
237 Adenosine A2 Receptor Antagonist - Pipeline Insight, 2022 Report Link
238 Anti-CD33 Antibody - Pipeline Insight, 2022 Report Link
239 Wnt Signaling Pathway Inhibitor - Pipeline Insight, 2022 Report Link
240 Alpha-2 Agonist - Pipeline Insight, 2022 Report Link
241 Adenosine A2A Receptor Agonist - Pipeline Insight, 2022 Report Link
242 Xanthine Oxidase Inhibitor - Pipeline Insight, 2022 Report Link
243 Anti-CD37 Antibody - Pipeline Insight, 2022 Report Link
244 Alpha-2 Antagonist - Pipeline Insight, 2022 Report Link
245 Adenosine A2A Receptor Antagonist - Pipeline Insight, 2022 Report Link
246 Alpha-Amylase Inhibitor - Pipeline Insight, 2022 Report Link
247 Anti-CD38 Antibody - Pipeline Insight, 2022 Report Link
248 Beta-1 Receptors Agonist - Pipeline Insight, 2022 Report Link
249 Adenosine A2B Receptor Antagonist - Pipeline Insight, 2022 Report Link
250 Anti-CD40 Antibody - Pipeline Insight, 2022 Report Link
251 Alpha-Synuclein (alphaSyn or SNCA) Inhibitor - Pipeline Insight, 2022 Report Link
252 Adenosine A3 Receptor Agonist - Pipeline Insight, 2022 Report Link
253 Beta-2 Receptors Antagonist - Pipeline Insight, 2022 Report Link
254 Anti-CD52 Antibody - Pipeline Insight, 2022 Report Link
255 AMPA Receptor Antagonist - Pipeline Insight, 2022 Report Link
256 Adenosine A3 Receptor Antagonist - Pipeline Insight, 2022 Report Link
257 Beta-2 Receptors Agonist - Pipeline Insight, 2022 Report Link
258 Anti-CD80 Antibody - Pipeline Insight, 2022 Report Link
259 Adenosine Antagonist - Pipeline Insight, 2022 Report Link
260 Amyloid Protein Blockers - Pipeline Insight, 2022 Report Link
261 Beta-3 Receptors Agonist - Pipeline Insight, 2022 Report Link
262 Anti-Dickkopf-1 (Dkk-1) Antibody - Pipeline Insight, 2022 Report Link
263 Anaplastic Lymphoma Kinase (ALK) Inhibitors - Pipeline Insight, 2022 Report Link
264 Beta-Lactamase Inhibitor - Pipeline Insight, 2022 Report Link
265 Adrenergic Antagonist - Pipeline Insight, 2022 Report Link
266 Anti-Lymphotoxin - Pipeline Insight, 2022 Report Link
267 Androgen Agonist - Pipeline Insight, 2022 Report Link
268 Adrenergic Uptake Inhibitor - Pipeline Insight, 2022 Report Link
269 Blood Coagulation Factor Activators - Pipeline Insight, 2022 Report Link
270 Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2022 Report Link
271 Androgen Antagonist - Pipeline Insight, 2022 Report Link
272 Bradykinin Antagonist - Pipeline Insight, 2022 Report Link
273 Akt1 Inhibitor - Pipeline Insight, 2022 Report Link
274 Apolipoprotein B (ApoB) Inhibitor - Pipeline Insight, 2022 Report Link
275 Angiopoietin Inhibitor - Pipeline Insight, 2022 Report Link
276 Aldose Reductase Inhibitor - Pipeline Insight, 2022 Report Link
277 Bradykinin Receptor B1 Antagonist - Pipeline Insight, 2022 Report Link
278 Apoptosis Inhibitor - Pipeline Insight, 2022 Report Link
279 Angiopoietin 2 (Ang-2) Inhibitor - Pipeline Insight, 2022 Report Link
280 Aldosterone Antagonist - Pipeline Insight, 2022 Report Link
281 Bradykinin Receptor B2 Antagonist - Pipeline Insight, 2022 Report Link
282 Arginine Depletors - Pipeline Insight, 2022 Report Link
283 Angiotensin Converting Enzyme (ACE) Inhibitor - Pipeline Insight, 2022 Report Link
284 BRAFV600 mutation (B-Raf proto-oncogene, serine/threonine kinase) Inhibiotors - Pipeline Insight, 2022 Report Link
285 Alpha 4 Beta 2 Neuronal Nicotinic Receptor (NNR) Agonist - Pipeline Insight, 2022 Report Link
286 ATP Binding Cassette Sub Family B member 1 (ABCB1 or P-Glycoprotein or P-gp) Inhibitor - Pipeline Insight, 2022 Report Link
287 Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator - Pipeline Insight, 2022 Report Link
288 Broad Spectrum Chemokine Inhibitor (BSCIs) - Pipeline Insight, 2022 Report Link
289 Alpha 4 Beta 7 (A4b7) Integrin Inhibitor- - Pipeline Insight, 2022 Report Link
290 ATPase Inhibitor - Pipeline Insight, 2022 Report Link
291 Angiotensin II Receptor Type 2 (AT2 Receptor) Inhibitor - Pipeline Insight, 2022 Report Link
292 Alpha Glucosidase Inhibitor - Pipeline Insight, 2022 Report Link
293 Brutons Tyrosine Kinase (BTK) Inhibitors - Pipeline Insight, 2022 Report Link
294 Aurora Kinase Inhibitor - Pipeline Insight, 2022 Report Link
295 Angiotensin Modulators - Pipeline Insight, 2022 Report Link
296 Alpha Receptor Agonist - Pipeline Insight, 2022 Report Link
297 C1 Esterase Inhibitor - Pipeline Insight, 2022 Report Link
298 Autophagy modulators - Pipeline Insight, 2022 Report Link
299 Angiotensin Receptor Agonist - Pipeline Insight, 2022 Report Link
300 Alpha Receptor Antagonist - Pipeline Insight, 2022 Report Link
301 C5a Receptor Antagonist - Pipeline Insight, 2022 Report Link
302 Anti GM-CSF Antibody - Pipeline Insight, 2022 Report Link
303 B-Cell Activating Factor (BAFF) Inhibitor - Pipeline Insight, 2022 Report Link
304 Alpha v Beta 3/5/6 Integrin Antagonist - Pipeline Insight, 2022 Report Link
305 Bcl-xL Protein Inhibitor - Pipeline Insight, 2022 Report Link
306 Anti-CD152 Antibody - Pipeline Insight, 2022 Report Link
307 Alpha v Beta 3 Integrin Antagonist - Pipeline Insight, 2022 Report Link
308 Cannabinoid Agonist - Pipeline Insight, 2022 Report Link
309 Anti-CD19 Antibody - Pipeline Insight, 2022 Report Link
310 Bcr-Abl Tyrosine Kinase Inhibitor - Pipeline Insight, 2022 Report Link
311 Cannabinoid Receptor Type 1 (CB1) Agonist - Pipeline Insight, 2022 Report Link
312 Alpha v Beta 5 Integrin Antagonist - Pipeline Insight, 2022 Report Link
313 Benzodiazepine Receptor Agonist - Pipeline Insight, 2022 Report Link
314 Anti-CD274 (PD-L1) Antibody - Pipeline Insight, 2022 Report Link
315 Cannabinoid Receptor Type 1 (CB1) Antagonist - Pipeline Insight, 2022 Report Link
316 Alpha-1 Agonist - Pipeline Insight, 2022 Report Link
317 Cannabinoid Receptor Type 2 (CB2) Agonist - Pipeline Insight, 2022 Report Link
318 Beta Receptor Agonist - Pipeline Insight, 2022 Report Link
319 Anti-CD279 (PD-1) Antibody - Pipeline Insight, 2022 Report Link
320 Carbonic Anhydrase Inhibitor - Pipeline Insight, 2022 Report Link
321 Beta Receptor Antagonist - Pipeline Insight, 2022 Report Link
322 Anti-CD28 Antibody - Pipeline Insight, 2022 Report Link
323 Carnitine Palmitoyltransferase I (CPT 1) Inhibitor - Pipeline Insight, 2022 Report Link
324 Anti-CD3 Antibody - Pipeline Insight, 2022 Report Link
325 Beta Secretase Inhibitor - Pipeline Insight, 2022 Report Link
326 Beta Selective Thyroid Hormone Receptor Agonist - Pipeline Insight, 2022 Report Link
327 Casein Kinase 2 Inhibitor - Pipeline Insight, 2022 Report Link
328 Beta-1 Receptors Antagonist - Pipeline Insight, 2022 Report Link
329 Caspase 3 (CPP32, Apopain or YAMA) Activators - Pipeline Insight, 2022 Report Link
330 Caspases Activators - Pipeline Insight, 2022 Report Link
331 Caspases Inhibitor - Pipeline Insight, 2022 Report Link
332 Catechol-O-methyltransferase (COMT) Inhibitor - Pipeline Insight, 2022 Report Link
333 Cathepsin K/S Inhibitor - Pipeline Insight, 2022 Report Link
334 Cathepsin K Inhibitor - Pipeline Insight, 2022 Report Link
335 Cathepsin S inhibitor - Pipeline Insight, 2022 Report Link
336 Cholesterol Absorption Inhibitor - Pipeline Insight, 2022 Report Link
337 CCR Inhibitor - Pipeline Insight, 2022 Report Link
338 Cholesterylester Transfer Protein (CETP) Inhibitor - Pipeline Insight, 2022 Report Link
339 CCR1 Inhibitor - Pipeline Insight, 2022 Report Link
340 C-Raf Kinase Inhibitor - Pipeline Insight, 2022 Report Link
341 CCR2 Inhibitor - Pipeline Insight, 2022 Report Link
342 CRF1 Receptor Antagonist - Pipeline Insight, 2022 Report Link
343 CCR3 Inhibitor - Pipeline Insight, 2022 Report Link
344 Diglyceride Acyltransferase (DGAT) Inhibitor - Pipeline Insight, 2022 Report Link
345 CXCR4 Inhibitor - Pipeline Insight, 2022 Report Link
346 CCR4 Inhibitor - Pipeline Insight, 2022 Report Link
347 Dihydroorotate Dehydrogenase (DHODH) Inhibitor - Pipeline Insight, 2022 Report Link
348 Cyclin-Dependent Kinase Inhibitor - Pipeline Insight, 2022 Report Link
349 CCR5 Inhibitor - Pipeline Insight, 2022 Report Link
350 DNA Methyltransferase Inhibitor - Pipeline Insight, 2022 Report Link
351 Cyclin-Dependent Kinase 1 (CDK1) Inhibitor - Pipeline Insight, 2022 Report Link
352 CD (Cluster of Differentiation) Inhibitor - Pipeline Insight, 2022 Report Link
353 Fatty Acid Synthase (FAS) Inhibitor - Pipeline Insight, 2022 Report Link
354 DNA-Dependent RNA Polymerase Inhibitor - Pipeline Insight, 2022 Report Link
355 Cyclin-Dependent Kinase 2 (CDK2) Inhibitor - Pipeline Insight, 2022 Report Link
356 CD 19 Inhibitor - Pipeline Insight, 2022 Report Link
357 Dopaminergic Agonist - Pipeline Insight, 2022 Report Link
358 Fc-Gamma Receptor Antagonist - Pipeline Insight, 2022 Report Link
359 Cyclin-Dependent Kinase 6/4 (CDK6/4) Inhibitor - Pipeline Insight, 2022 Report Link
360 CD 3 Inhibitor - Pipeline Insight, 2022 Report Link
361 Dopaminergic system Antagonist - Pipeline Insight, 2022 Report Link
362 Cyclin-Dependent Kinase 9 (CDK9) Inhibitor - Pipeline Insight, 2022 Report Link
363 CD 33 Inhibitor - Pipeline Insight, 2022 Report Link
364 DP1 Receptor (Prostaglandin D2 receptor) Antagonist - Pipeline Insight, 2022 Report Link
365 Cyclophilin Inhibitor - Pipeline Insight, 2022 Report Link
366 Fibroblast Growth Factor (FGF) Inhibitor - Pipeline Insight, 2022 Report Link
367 CD 40 Inhibitor - Pipeline Insight, 2022 Report Link
368 DP2 Receptor (G Protein-Coupled Receptor 44 or Chemoattractant Receptor-Homologous Molecule On Th2 Cells (CRTH2)) Antagonist - Pipeline Insight, 2022 Report Link
369 CD152 Inhibitor - Pipeline Insight, 2022 Report Link
370 Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Inhibitor - Pipeline Insight, 2022 Report Link
371 Fibroblast Growth Factor 1 (FGF-1) Inhibitor - Pipeline Insight, 2022 Report Link
372 Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitor - Pipeline Insight, 2022 Report Link
373 Cystic Fibrosis Transmembrane Conductance Regulators (CFTR) - Pipeline Insight, 2022 Report Link
374 CD40 Agonist - Pipeline Insight, 2022 Report Link
375 Focal Adhesion Kinase (FAK) Inhibitor - Pipeline Insight, 2022 Report Link
376 Cytochrome P450 Superfamily (CYP or CYP450) Inhibitor - Pipeline Insight, 2022 Report Link
377 Cell Division Cycle 7 (CDC7) Related Protein Kinase Inhibitor - Pipeline Insight, 2022 Report Link
378 Cell Wall Synthesis Inhibitors - Pipeline Insight, 2022 Report Link
379 Fusion Inhibitor - Pipeline Insight, 2022 Report Link
380 Cytochrome P450 17 (CYP17) Inhibitor - Pipeline Insight, 2022 Report Link
381 D Agonist - Pipeline Insight, 2022 Report Link
382 cFMS Kinase Inhibitor - Pipeline Insight, 2022 Report Link
383 G2 Checkpoint Inhibitor - Pipeline Insight, 2022 Report Link
384 Checkpoint Kinase Inhibitor - Pipeline Insight, 2022 Report Link
385 D Antagonist - Pipeline Insight, 2022 Report Link
386 GABA Receptor Agonist - Pipeline Insight, 2022 Report Link
387 GABA Receptor Antagonist - Pipeline Insight, 2022 Report Link
388 Checkpoint Kinase 1 (Chk1) Inhibitor - Pipeline Insight, 2022 Report Link
389 D1 Agonist - Pipeline Insight, 2022 Report Link
390 D1 Antagonist - Pipeline Insight, 2022 Report Link
391 GABA Receptor Modulators - Pipeline Insight, 2022 Report Link
392 Checkpoint Kinase 2 (Chk2) Inhibitor - Pipeline Insight, 2022 Report Link
393 GABA Transaminase Inhibitor - Pipeline Insight, 2022 Report Link
394 D2 Agonist - Pipeline Insight, 2022 Report Link
395 Chemokine Receptor Antagonist - Pipeline Insight, 2022 Report Link
396 Cholecystokinin Receptor (CCK) Antagonist - Pipeline Insight, 2022 Report Link
397 GABAA Agonist - Pipeline Insight, 2022 Report Link
398 D3 Agonist - Pipeline Insight, 2022 Report Link
399 GABAA Modulators - Pipeline Insight, 2022 Report Link
400 D3 Antagonist - Pipeline Insight, 2022 Report Link
401 D4 Agonist - Pipeline Insight, 2022 Report Link
402 D4 Antagonist - Pipeline Insight, 2022 Report Link
403 Delta Antagonist - Pipeline Insight, 2022 Report Link
404 Eg5 Inhibitor - Pipeline Insight, 2022 Report Link
405 Elastase Inhibitor - Pipeline Insight, 2022 Report Link
406 Endothelin Receptor (ET) Antagonist - Pipeline Insight, 2022 Report Link
407 Endothelin Receptor A (ETA) Antagonist - Pipeline Insight, 2022 Report Link
408 Enhancer of zeste homolog 2 (EZH2) Inhibitor - Pipeline Insight, 2022 Report Link
409 Ephrin (EPH) Receptor Antagonist - Pipeline Insight, 2022 Report Link
410 Ephrin Type A Receptor 2 (EPH Receptor A2 or EPHA2) Antagonist - Pipeline Insight, 2022 Report Link
411 Epithelial Sodium Channel (ENaC) Inhibitor - Pipeline Insight, 2022 Report Link
412 Estrogen Receptor Beta Partial Agonist - Pipeline Insight, 2022 Report Link
413 Factor II (Prothrombin) Inhibitor - Pipeline Insight, 2022 Report Link
414 Factor IIa (Thrombin) Inhibitor - Pipeline Insight, 2022 Report Link
415 Factor IX - Pipeline Insight, 2022 Report Link
416 Factor IX A Inhibitor - Pipeline Insight, 2022 Report Link
417 Factor VIIa Inhibitor - Pipeline Insight, 2022 Report Link
418 Factor VIII Inhibitor - Pipeline Insight, 2022 Report Link
419 Farnesoid X Receptor (FXR) Agonist - Pipeline Insight, 2022 Report Link
420 Fatty Acid Amide Hydrolase (FAAH) Inhibitor - Pipeline Insight, 2022 Report Link
421 NF-Kappa B Inhibitors – Pipeline Insights, 2022 Report Link
422 CD137 Agonist Antibody - Pipeline Insight, 2022 Report Link
423 C-X-C Chemokine Receptor (CXCR) Inhibitors - Pipeline Insight, 2022 Report Link
424 RIPK1 Inhibitor - Pipeline Insight, 2022 Report Link
425 Toll-Like Receptor 3 (TLR-3) Agonist - Pipeline Insight, 2022 Report Link
426 Relapsed and Refractory CD5-Expressing T Cell Lymphomas - Pipeline Insight, 2022 Report Link
427 AXL Kinase Inhibitor - Pipeline Insight, 2022 Report Link
428 Cytidine Deaminase Inhibitors (CDA) - Pipeline Insight, 2022 Report Link
429 TIM-3 Inhibitor - Pipeline Insight, 2022 Report Link
430 Anti-CD22 Therapies - Pipeline Insight, 2022 Report Link
431 Anti-CD30 Therapies - Pipeline Insight, 2022 Report Link
432 Oncolytic Virus Cancer Therapy - Pipeline Insight, 2022 Report Link
433 mTORC1 Protein Inhibitors - Pipeline Insight, 2022 Report Link
434 Acetyl-CoA Carboxylase Inhibitors - Pipeline Insight, 2022 Report Link
435 Sphingosine 1 Phosphate Receptor Modulators - Pipeline Insight, 2022 Report Link
436 Selective Estrogen Receptor Degraders - Pipeline Insight, 2022 Report Link
437 Amyloid Beta-Protein Inhibitors - Pipeline Insight, 2022 Report Link
438 Protein 50S Ribosomal Subunit Inhibitors - Pipeline Insight, 2022 Report Link
439 Opioid Kappa Receptor Agonists - Pipeline Insight, 2022 Report Link
440 Serotonin 3 Receptor Antagonists - Pipeline Insight, 2022 Report Link
441 Dopamine D1 Receptor Antagonists - Pipeline Insight, 2022 Report Link
442 CXCR4 Receptor Antagonists - Pipeline Insight, 2022 Report Link
443 Complement C1 Inhibitors - Pipeline Insight, 2022 Report Link
444 Type 1 Fibroblast Growth Factor Receptor Antagonists - Pipeline Insight, 2022 Report Link
445 Cannabinoid Receptor CB1 Inverse Agonists - Pipeline Insight, 2022 Report Link
446 Acetylcholine Inhibitors - Pipeline Insight, 2022 Report Link
447 Interleukin 1 Beta Inhibitors - Pipeline Insight, 2022 Report Link
448 Type 4 Cyclic Nucleotide Phosphodiesterase Inhibitors - Pipeline Insight, 2022 Report Link
449 TYK2 Kinase Inhibitors - Pipeline Insight, 2022 Report Link
450 Histamine H1 Receptor Antagonists - Pipeline Insight, 2022 Report Link
451 T Type Calcium Channel Antagonists - Pipeline Insight, 2022 Report Link
452 Thyroid Hormone Receptor Agonists - Pipeline Insight, 2022 Report Link
453 Dipeptidyl Peptidase 4 Inhibitors - Pipeline Insight, 2022 Report Link
454 Serotonin 1B Receptor Agonists - Pipeline Insight, 2022 Report Link
455 Proteasome Inhibitors - Pipeline Insight, 2022 Report Link
456 Sodium Channel Blockers - Pipeline Insight, 2022 Report Link
457 Placenta Growth Factor Inhibitors - Pipeline Insight, 2022 Report Link
458 Alpha-Synuclein Inhibitors - Pipeline Insight, 2022 Report Link
459 14-Alpha Demethylase Inhibitors - Pipeline Insight, 2022 Report Link
460 Complement C5 Inhibitors - Pipeline Insight, 2022 Report Link
461 CD3 Antigen Inhibitors - Pipeline Insight, 2022 Report Link
462 Epidermal Growth Factor Receptor Antagonists - Pipeline Insight, 2022 Report Link
463 Exosomes - Pipeline Insight, 2022 Report Link
464 HAVCR2 Protein Inhibitors - Pipeline Insight, 2022 Report Link
465 CD47 Antigen Inhibitors - Pipeline Insight, 2022 Report Link
466 Alpha 1 Adrenergic Receptor Antagonist - Pipeline Insight, 2022 Report Link
467 Interleukin 6 Inhibitors - Pipeline Insight, 2022 Report Link
468 Angiotensin Type 1 Receptor Antagonists - Pipeline Insight, 2022 Report Link
469 Nociceptin Receptor Agonists - Pipeline Insight, 2022 Report Link
470 Proto Oncogene Protein c-myc Inhibitors - Pipeline Insight, 2022 Report Link
471 Thymidylate Synthase Inhibitors - Pipeline Insight, 2022 Report Link
472 Proto Oncogene Protein c-akt Inhibitors - Pipeline Insight, 2022 Report Link
473 ROS1 Protein Inhibitors - Pipeline Insight, 2022 Report Link
474 TIGIT Inhibitors - Pipeline Insight, 2022 Report Link
475 P53 Antigen Modulators - Pipeline Insight, 2022 Report Link
476 Discoidin Domain Receptor Antagonists - Pipeline Insight, 2022 Report Link
477 ANGPTL3 Protein Inhibitors - Pipeline Insight, 2022 Report Link
478 Poly(ADP-ribose) Polymerase Inhibitors - Pipeline Insight, 2022 Report Link
479 ATR Protein Inhibitors - Pipeline Insight, 2022 Report Link
480 Coronavirus-3C-like-Proteinase Inhibitors - Pipeline Insight, 2022 Report Link
481 Sigma-1 Receptor Agonists - Pipeline Insight, 2022 Report Link
482 Integrin Alpha4beta1 Antagonists - Pipeline Insight, 2022 Report Link
483 Interleukin 8 Receptor Antagonists - Pipeline Insight, 2022 Report Link
484 TRAIL Receptor 2 Agonists - Pipeline Insight, 2022 Report Link
485 TIE-2 Receptor Agonists - Pipeline Insight, 2022 Report Link
486 Vascular Endothelial Growth Factor Receptor-2 Antagonists - Pipeline Insight, 2022 Report Link
487 Aminopeptidase Inhibitors - Pipeline Insight, 2022 Report Link
488 Type-2 Fibroblast Growth Factor Receptor Antagonists - Pipeline Insight, 2022 Report Link
489 Vascular Endothelial Growth Factor Receptor 3 Antagonists - Pipeline Insight, 2022 Report Link
490 NLRP3 Protein Inhibitors - Pipeline Insight, 2022 Report Link
491 Apolipoprotein C-III Inhibitors - Pipeline Insight, 2022 Report Link
492 Aldosterone Synthase Inhibitors - Pipeline Insight, 2022 Report Link
493 Cyclo-Oxygenase 2 Inhibitors - Pipeline Insight, 2022 Report Link
494 Macrophage Colony Stimulating Factor Receptor Antagonists - Pipeline Insight, 2022 Report Link
495 IgE Receptor Antagonists - Pipeline Insight, 2022 Report Link
496 Purinoceptor P2Y12 Antagonists - Pipeline Insight, 2022 Report Link
497 ACVR1 Protein Inhibitors - Pipeline Insight, 2022 Report Link
498 MAP Kinase Kinase 1 Inhibitors - Pipeline Insight, 2022 Report Link
499 Capsid Protein Inhibitors - Pipeline Insight, 2022 Report Link
500 Viral Core Protein Inhibitors - Pipeline Insight, 2022 Report Link
501 Histone Deacetylase 6 (HDAC 6) Inhibitors - Pipeline Insight, 2022 Report Link
502 Factor XI Inhibitors - Pipeline Insight, 2022 Report Link
503 Protein-Tyrosine-Phosphatase Inhibitors - Pipeline Insight, 2022 Report Link
504 Proto-Oncogene Protein c-bcl-2 Inhibitors - Pipeline Insight, 2022 Report Link
505 Complement C3 Inhibitors - Pipeline Insight, 2022 Report Link
506 Interleukin-12 Expression Stimulants - Pipeline Insight, 2022 Report Link
507 Proto Oncogene Proteins C PIM 1 Inhibitors - Pipeline Insight, 2022 Report Link
508 Nitric Oxide Synthase Inhibitor - Pipeline Insight, 2022 Report Link
509 BRD4 Protein Inhibitor - Pipeline Insight, 2022 Report Link
510 Proto-Oncogene Protein c mdm2 Inhibitors - Pipeline Isnight, 2022 Report Link
511 TRPV1 Receptor Antagonists - Pipeline Insight, 2022 Report Link
512 Notch Receptor Antagonists - Pipeline Insight, 2022 Report Link
513 Endothelial PAS Domain-Containing Protein 1 Inhibitors - Pipeline Insight, 2022 Report Link
514 CD33 Antigen Inhibitors - Pipeline Insight, 2022 Report Link
515 ERBB 2 Receptor Antagonists - Pipeline Insight, 2022 Report Link
516 MALT1 Protein Inhibitor - Pipeline Insight, 2022 Report Link
517 MCL1 Protein Inhibitor - Pipeline Insight, 2022 Report Link
518 Alpha4beta7 Integrin Antagonists - Pipeline Insight, 2022 Report Link
519 Interleukin 4 Inhibitors - Pipeline Insight, 2022 Report Link
520 Complement C1s Inhibitors - Pipeline Insight, 2022 Report Link
521 Neonatal Fc Receptor Antagonists- Pipeline Insight, 2022 Report Link
522 MPYS Protein Inhibitors - Pipeline Insight, 2022 Report Link
523 Enoyl-ACP Reductase Inhibitors - Pipeline Insight, 2022 Report Link
524 MPYS Protein Stimulants - Pipeline Insight, 2022 Report Link
525 PRMT5 Protein Inhibitors - Pipeline Insight, 2022 Report Link
526 Hematopoietic Progenitor Kinase 1 Inhibitors - Pipeline Insight, 2022 Report Link
527 Phosphatidylinositol 3 Kinase Delta Inhibitors - Pipeline Insight, 2022 Report Link
528 TrkC Receptor Antagonists - Pipeline Insight, 2022 Report Link
529 Type II DNA Topoisomerase inhibitors - Pipeline Insight, 2022 Report Link
530 DNA Topoisomerase I Inhibitors - Pipeline Insight, 2022 Report Link
531 Ribonucleotide Reductase Inhibitors - Pipeline Insight, 2022 Report Link
532 WEE1 Protein Inhibitors - Pipeline Insight, 2022 Report Link
533 Protein Tyrosine Phosphatase Non Receptor Type 11 Antagonists - Pipeline Insight, 2022 Report Link
534 DUX4 Protein Inhibitors - Pipeline Insight, 2022 Report Link
535 P38 Mitogen-Activated Protein (MAP) Kinase Inhibitors - Pipeline Insight, 2022 Report Link
536 RNA Interference- Pipeline Insight, 2022 Report Link